Skip to Content

Rigel Pharmaceuticals Inc RIGL

Trading Information

Previous Close Price
$1.49
Day Range
$1.461.51
52-Week Range
$0.711.96
Bid/Ask
$1.48 / $1.65
Market Cap
$259.56 Mil
Volume/Avg
782,389 / 1.2 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.20
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Growth
Total Number of Employees
147

Comparables

Valuation

Metric
RIGL
ALVR
CHRS
Price/Earnings (Normalized)
Price/Book Value
0.59
Price/Sales
2.200.87
Price/Cash Flow
Price/Earnings
RIGL
ALVR
CHRS

Financial Strength

Metric
RIGL
ALVR
CHRS
Quick Ratio
1.646.491.14
Current Ratio
1.866.611.43
Interest Coverage
−2.98−4.88
Quick Ratio
RIGL
ALVR
CHRS

Profitability

Metric
RIGL
ALVR
CHRS
Return on Assets (Normalized)
−13.18%−52.75%−27.74%
Return on Equity (Normalized)
−66.34%
Return on Invested Capital (Normalized)
−36.17%−59.54%−32.60%
Return on Assets
RIGL
ALVR
CHRS
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRWhdzksjhrLltd$570.1 Bil
VRTX
Vertex Pharmaceuticals IncXsqvdnmhTbdmrt$108.0 Bil
REGN
Regeneron Pharmaceuticals IncPwlpytzfzShwcb$105.6 Bil
MRNA
Moderna IncSznghkgbzVftsz$40.8 Bil
ARGX
argenx SE ADRQqdpnjbwDtr$23.5 Bil
BNTX
BioNTech SE ADRPjdppklRcz$21.9 Bil
ALNY
Alnylam Pharmaceuticals IncBsbvwfzrpMqgwdrf$18.8 Bil
BMRN
Biomarin Pharmaceutical IncQfklwglwHgcvxqr$16.5 Bil
RPRX
Royalty Pharma PLC Class AWwxgzmyfmDgyjdb$13.6 Bil
INCY
Incyte CorpKlhlpbcKrggmz$12.8 Bil

Sponsor Center